We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SERA market cap is 340M. The company's latest EPS is USD -1.1565 and P/E is -9.35.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 87k | 65k | 100k | 123k | 42k |
| Operating Income | -11.19M | -10.42M | -11.33M | -11.46M | -8.18M |
| Net Income | -10.71M | -9.75M | -10.57M | -10.54M | -7.21M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 36k | 25k | 82k | 268k | 306k |
| Operating Income | -16.58M | -17.97M | -35.4M | -45.65M | -39.82M |
| Net Income | -16.52M | -19.85M | -35.01M | -44.19M | -36.24M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 116.56M | 116.33M | 105.61M | 96.68M | 90.06M |
| Total Liabilities | 9.4M | 17.39M | 15.4M | 15.54M | 14.65M |
| Total Equity | 107.16M | 98.94M | 90.21M | 81.14M | 75.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23.26M | 14.8M | 147.03M | 116.33M | 95.44M |
| Total Liabilities | 12.53M | 12.33M | 8.47M | 17.39M | 25.28M |
| Total Equity | -106.62M | -125.57M | 138.56M | 98.94M | 70.16M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.37M | -34.61M | -4.88M | -12.83M | -20.42M |
| Investing | 7.13M | 5.55M | 2.32M | 15.23M | 64k |
| Financing | 121k | 5k | -116k | 8k | 136k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.32M | -16.87M | -31.64M | -34.61M | -27.19M |
| Investing | -6k | -149k | -82.56M | 5.55M | 438k |
| Financing | 33.05M | 9.16M | 159.59M | 5k | 752k |
| Market Cap | 340M |
| Price to Earnings Ratio | -9.35 |
| Price to Sales Ratio | 1.1k |
| Price to Cash Ratio | 87.32 |
| Price to Book Ratio | 4.83 |
| Dividend Yield | - |
| Shares Outstanding | 31.34M |
| Average Volume (1 week) | 100.59k |
| Average Volume (1 Month) | 134.18k |
| 52 Week Change | 221.01% |
| 52 Week High | 12.355 |
| 52 Week Low | 1.52 |
| Spread (Intraday) | 0.21 (1.9%) |
| Company Name | Sera Prognostics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.seraprognostics.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
